Technical Analysis for ARKG - ARK Genomic Revolution Multi-Sector ETF

Grade Last Price % Change Price Change
grade C 29.0135 1.27% 0.36
ARKG closed up 1.27 percent on Friday, February 15, 2019, on 50 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ARKG trend table...

Date Alert Name Type % Chg
Feb 15 Overbought Stochastic Strength 0.00%
Feb 14 Narrow Range Bar Range Contraction 1.27%
Feb 14 NR7 Range Contraction 1.27%
Feb 14 Stochastic Reached Overbought Strength 1.27%
Feb 14 BB Squeeze Ended Range Expansion 1.27%
Feb 14 Overbought Stochastic Strength 1.27%
Feb 13 MACD Bullish Signal Line Cross Bullish 0.95%
Feb 13 Pocket Pivot Bullish Swing Setup 0.95%
Feb 13 Bollinger Band Squeeze Range Contraction 0.95%
Feb 13 Narrow Range Bar Range Contraction 0.95%

Older signals for ARKG ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Exchange Traded Funds Energy Healthcare Information Technology SPDR Genomics
Is ARKG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Feb 4 New ETF Launches to Take Advantage of Growing Fintech Industry
Jan 24 ARKG: Investing To Profit From The Genomic Revolution
Jan 15 FDA Commish touts advances/successes
Jan 14 Rep. Cummings opens investigation into drug prices
Jan 14 Best & Worst Performing ETFs to Start 2019
Jan 2 Drug makers OK with price inclusion in TV ads if done fairly
Jan 2 U.S. government shutdown hampers FDA
Dec 13 Senate Dems introduce bill to block "excessive" increases in drug prices
Dec 4 An ETF to Capture Biotech’s Breakthrough of the Century
Dec 3 The Power of Genome Editing: What Investors Should Know
See more ARKG news...
Indicators
Indicator Value
52 Week High 34.69
52 Week Low 21.98
Average Volume 139,498
200-Day Moving Average 29.3318
50-Day Moving Average 27.0721
20-Day Moving Average 28.1002
10-Day Moving Average 28.3674
Average True Range 0.6896
ADX 16.61
+DI 33.3755
-DI 20.0837
Chandelier Exit (Long, 3 ATRs ) 27.0412
Chandelier Exit (Short, 3 ATRs ) 28.9388
Upper Bollinger Band 29.1791
Lower Bollinger Band 27.0213
Percent B (%b) 0.92
BandWidth 7.678949
MACD Line 0.4002
MACD Signal Line 0.3485
MACD Histogram 0.0517
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.75
Resistance 3 (R3) 29.70 29.40 29.63
Resistance 2 (R2) 29.40 29.22 29.43 29.59
Resistance 1 (R1) 29.21 29.10 29.31 29.26 29.54
Pivot Point 28.91 28.91 28.96 28.94 28.91
Support 1 (S1) 28.72 28.73 28.82 28.77 28.48
Support 2 (S2) 28.42 28.61 28.45 28.44
Support 3 (S3) 28.23 28.42 28.40
Support 4 (S4) 28.28